Abstract: SA-PO429
Interventions Required for Use of a Wearable Device in Hemodialysis Patients
Session Information
- Hemodialysis and Frequent Dialysis: Clearance, Technology, Infection
November 05, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
Abstract Time: 10:00 AM - 12:00 PM
Category: Dialysis
- 701 Dialysis: Hemodialysis and Frequent Dialysis
Authors
- Han, Maggie, Renal Research Institute, New York, New York, United States
- Thwin, Ohnmar, Renal Research Institute, New York, New York, United States
- Tao, Xia, Renal Research Institute, New York, New York, United States
- Rivera Fuentes, Lemuel, Renal Research Institute, New York, New York, United States
- Patel, Amrish U., Renal Research Institute, New York, New York, United States
- Kotanko, Peter, Renal Research Institute, New York, New York, United States
Background
Increased physical activity (PA) is associated with reduced risk of cardiovascular disease, which is prevalent in hemodialysis (HD) patients. Wearable activity trackers (WAT) allow the remote monitoring of PA. We aimed to explore what kinds of interventions are required to maintain use of WAT in a HD population
Methods
HD patients from 4 New York City clinics were enrolled on a rolling basis starting June 2018 and followed for up to 1 year. Ambulatory patients ≥18 years, on maintenance HD, and owning a mobile device were included. Each patient was provided with and taught how to use the Fitbit Charge 2. A stepwise intervention plan was used to assess feasibility (Figure 1). Patients were deemed non-compliant if they were withdrawn for non-compliance and patients who completed the 1-year follow up period were deemed compliant.
Results
119 patients were enrolled into the study. Patients were 54±12 years old, 59% African American, 37% lived alone, and 54% had an education level of college and above. 74 patients completed the study, 17 patients were withdrawn for non-compliance, 6 patients passed away, 12 patients were withdrawn due to kidney transplants, and 10 patients were withdrawn for other reasons. Results of the interventions deployed to compliant and non-compliant patients are shown in figure 2.
Conclusion
Patients who were non-compliant required a greater proportion of phone calls and in-person meetings, both interventions that cannot be automated, compared to their compliant counterparts. Patients who are more likely to be compliant, can maintain use of their wearable devices with automated text message reminders. When considering implementing a program using WAT in the HD population, an intervention-based program is necessary to guarantee adequate device usage and data collection.
Funding
- Commercial Support –